Obagi Medical Products (NASDAQ:OMPI) is a company whose shares are active, trading 2.2% higher to $14.19. The S&P is currently trading 0.3% lower to 1,514 and the Dow Jones Industrial Average is trading 0.3% lower to 14,044.
Potential upside of 2.2% exists for Obagi Medical Products, based on a current level of $14.19 and analysts' average consensus price target of $14.50. The stock should find initial support at its 50-day moving average (MA) of $13.89 and further support at its 200-day MA of $13.54.
Obagi Medical Products, Inc. develops skin care pharmaceuticals. The Company develops prescription topical treatments for premature aging, photo-damage, hyperpigmentation, acne, and soft tissue deficits such as fine lines and wrinkles.
Over the past year, Obagi Medical Products has traded in a range of $8.61 to $18.00 and is now at $14.19, 65% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has risen 0.2%.